Cargando...

The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis.

Sixteen women with multiple sclerosis who complained of nocturia completed a double-blind cross-over trial of Desmopressin (DDAVP) and placebo. Nocturia was reduced from a mean of 2.55 voids to 2.01 with placebo and to 1.28 with Desmopressin (p less than 0.01, for the difference between placebo and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hilton, P, Hertogs, K, Stanton, S L
Formato: Artigo
Idioma:Inglês
Publicado: 1983
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1027570/
https://ncbi.nlm.nih.gov/pubmed/6619893
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!